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Abstract: Pathological and immunohistochemical changes in livers were investigated in monocrotaline-treated rats. Eighty adult-male
Wistar rats were distributed in 5 groups, each containing 16 animals according to monocrotaline dose (Group I: 50 mg/kg, Group II:
100 mg/kg, Group III: 150 mg/kg, and Group IV: 200 mg/kg). The control group was administered with physiological saline. Half of the
animals in each group were euthanized at the 18th hour while the remaining half at the 6th week postinoculation. At the end of the 18th
hour, the most prominent lesion was hepatocytic apoptosis which was dose-dependent. Apoptotic cells were mostly located in periportal
and mid-zonal areas. The TUNEL staining was consistent with morphological findings. Mild to moderate sinusoidal congestion,
vacuolar and fatty degeneration were present in all the experimental groups. On the other hand, no difference was detected between
the experimental and control groups in proliferating cell antigen nuclear (PCNA) staining, whereas Bax/Bcl-2 staining was present in
all the experimental groups with a dose-dependent manner. At the end of the 6th week, hepatic megalocytosis, bile duct proliferation,
postnecrotic fibrosis were the main findings. The severity of the lesions was dose-dependent, and few intranuclear inclusion bodies were
also detected at the highest dose. At this period, hepatocytes were slightly stained by Bax and Bcl-2, whereas PCNA and TUNEL staining
were intensive. In conclusion, monocrotaline showed different effects on the liver depending on dose and duration of the exposure, and
the use of doses below 100 mg/kg may be recommended for long-term monocrotalin toxicity studies.
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1. Introduction
Pyrrolizidine alkaloids (PAs) are widely distributed
herbal toxins in nature [1-3]. There are about 660 PAs
with different structure determined in 6000 plant species
of 13 plant families [4-8]. Roughly, 3.0% of the world’s
flowering plants contain the PAs [2,9-12].
The liver is the primary target organ in PA toxication
[2,13]. Pyrrolic metabolites constitute the alkylating
reaction with the structural elements of tissues [14]. They
form covalent bonds with cellular structures such as DNA,
protein, amino acid, and glutathione [2,9,13]. Besides the
hepatotoxic effects, PAs have carcinogenetic [11,15-17],
antimitotic, and immunosuppressive effects [18].
The antimitotic effects are attributed to binding of the
pyrrolic metabolites to proteins or nucleic acids [3,11].
Pyrroles cause degeneration and necrosis in cells through
binding proteins of cytoplasm and the thiol groups of
nucleic acids [9,11]. Due to attachment of the metabolites
to the specific target regions on DNA, G2 and M phases
of mitosis do not occur; however, G1 and S phases are
not affected. Hepatocytes return to G1 phase again,
neglecting G2 or M, and protein synthesis continues in

the cell [2]. As a result of antimitotic effects, megalocytic
hepatocytes are formed in chronic toxication [1,19-21].
Mutagenic and teratogenic effects also occur when the
pyrollic metabolites bind to the DNA helix [13,22]. The
carcinogenic effect of PAs is caused by damage of the P53
gene in the DNA [22].
Monocrotaline is a pyrrolizidine alkaloid plant toxin
that causes hepatotoxic, pneumotoxic, genotoxic, and
nephrotoxic effects in human and animals [5,6,8,10,23].
Although there are many studies on pneumotoxic and
genotoxic effects of monocrotaline, its time course and
dose-related hepatotoxic effects have been examined in a
limited number of studies [6].
This study was performed to investigate the time
course and dose-related pathological findings induced by
monocrotaline in Wistar rat liver.
2. Materials and methods
2.1. Animals
The present study was approved by the Ethics Commission
of Fırat University in the convention on 05.02.2014 with
the decision number 38.
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Eighty adult-male Wistar rats were used in the study
which was performed at Fırat University Experimental
Animal Research Center (FUDAM). The animals were
divided into 5 groups including 4 experimental and one
control group. Each group consisted of 16 animals. During
the experiment, the rats were fed with standard rat diet
and water as ad libitum.
2.2. Monocrotaline
Monocrotaline in solid form (Crotaline, Sigma, Catalog
No. 315-22-0) was diluted with distilled water and
prepared 10% solution (100 mg monocrotaline in 1 mL).
The pH of the solution was regulated to 7.20 with addition
of sodium bicarbonate solution.
2.3. Experimental toxicology
At the beginning of the experiment, the rats were weighted
and recorded. When constituting the groups, the average
live weights of the rats in each group were paid attention to
be close to each other. Monocrotaline solution was injected
intraperitonally (i.p.) at the dose of 50 mg/kg, 100 mg/kg,
150 mg/kg, and 200 mg/kg to the Groups I, II, III, and IV,
respectively. The rats in the control group were injected
with a single dose of 1 mL serum physiological i.p.
2.4. Histopathological method
Systemic necropsy was performed in rats that died during
the experiment period and in those that were euthanized
at the end of experiment (18th hour and 6 weeks). Liver
samples were collected and fixed in 10% buffered formalin.
Paraffin blocks were cut at 3-5 μm thickness and the
sections were stained with hematoxylin-eosin (HE) for
routine histopathological examinations. Histopathological
findings were scored between 0 and 5 according to the
severity of the lesions. According to this score, 0 was
graded as no lesion, 1 to 2 as mild, 3 to 4 as moderate, and
5 as severe.
2.5. Immunohistochemical method
The liver sections were stained by avidin-biotincomplex (ABC; DAKO, Carpinteria, CA, USA) method
with proliferating cell nuclear antigen (PCNA, mouse,
monoclonal, 1:200, Santa Cruz), B-cell lymphoma (Bcl-2,
rabbit, polyclonal, 1:400, Santa Cruz), B-cell lymphoma
associated X protein (Bax, rabbit, polyclonal, 1:400, Santa
Cruz) primary antibodies to determine the rate of mitotic
activity. ABC staining method was used according to the
manufacturer’s protocol. Briefly, the sections were dewaxed
and rehydrated, and washed three times in phosphate
buffered saline (PBS) solution. For antigen retrieval,
sections were placed in coplin jar containing citrate buffer
solution (pH 6.0) and heated in microwave oven for 15
min at the highest power setting (distilled water was added
every 5 min). The jar was then removed from the oven
and allowed to cool slowly at room temperature. To block
endogenous peroxidase, the sections were treated with
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3.0% hydrogen peroxide in methanol for 5 min. Following
the incubation with blocking solution, the sections were
treated with primary antibodies (PCNA, Bcl-2, Bax) at
4.0 °C in a refrigerator overnight. After treatment with
biotinylated secondary antibody for 30 min, the slides
were incubated with strepavidin peroxidase for 30 min.
Except for incubation with blocking solution, slides were
washed with PBS 3 times for 5 min during all incubations
with reagent intervals. Following visualization of the
positive antigen-antibody reaction by incubating with
AEC chromogen, the slides were slightly counterstained
with Mayer hematoxylin.
2.6. TUNEL method
The liver sections were stained by using the terminal
deoxynucleotidyl transferase dUTP nick end-labeling
(TUNEL) method for detection of apoptosis. The TUNEL
staining was done using an Apoptag Plus Kit (Millipore,
Canada USA) according to the manufacturer’s protocol.
Mouse thyroid tissue which was fixed in formalin and
embedded in paraffin was used as positive control. A
previously experimentally degenerated mouse retina was
used as a control.
2.7. Calculation of live weight and organ
The rats were weighed before the trial and then once a
week from the start of the experiment during 6 weeks. The
Kruskal–Wallis variance analysis was used to determine
the statistical difference between the groups. The Mann–
Whitney U test was used to measure the difference
between the groups. Necropsy was performed on the
animals that died during the experiment and on those that
were euthanized at the end of the experiment, and organ
weights were determined.
3. Results
3.1. Live weights
Live weights of animals in the experimental groups were
lower than in the control group; however, there was no
significant difference between the experimental groups.
3.2. Clinical findings
In the high-dose-administered groups (Groups III and
IV); weakness, unresponsiveness to external stimuli,
anorexia, reluctance to move, and weight loss were noted
from the first week to the end of the study when compared
to the control group. The deaths in the experimental
groups were recorded as two rats in Group I (on the 37th
and 39th days), six rats in Group II (one each on the 29th
and 30th days and four on the 40th day), seven rats in
Group III (three on the 4th day, two on the 6th day, and
one each on the 39th and 40th days), and seven rats in
Group IV (three on the 7th day, and two each on the 8th
and 38th days). No death occurred in the Control group.
At the 18th hour of postinoculation, 8 animals from each
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group were euthanized and necropsied. In the long-term
trial period, animals that died after the 35th day and those
that remained alive until the end of the trial were evaluated
within the scope of the 6th week.
3.3. Gross findings
In the necropsy performed at the end of the 18th hour, the
macroscopic findings in Groups I, II, and III were milder
than those in Group IV. In Group II, a moderate icterus
was present on the serosal surfaces in the abdominal cavity
in addition to like honeycomb pethechiae on the liver
lobes of an animal that died on the 29th day. There was a
coconut-like appearance in visceral surface, milier shape
and pale white foci in the livers of the animals that died
on the 7th and 8th days in Groups III and IV. In Group IV,
2–4 mL of light yellow and clear ascites fluid in abdominal
cavity of 3 animals necropsied at the end of 18th hour were
noted.
3.4. Liver weights
A statistically significant difference was detected between
the experimental and control groups in terms of liver
weights at the 18th hour of the study, whereas the difference
among the experimental groups was not significant
(Tables 1 and 2). At the end of the 6th week, a statistically
significant difference was present between Group I, Group
II, Group III, Group IV, and Group V (control).
3.5. Microscopic findings
3.5.1 Microscopic findings in the liver of rats euthanized
at the end of the 18th hour
Semiquantitative evaluation of histopathological findings
in liver at the end of 18th hour was summarized in Table
3. In all experimental groups, vacuolar degeneration and
Kupffer cell activation were observed at varying degrees of

severity in addition to focal necrosis foci. Histopathological
changes were more severe in the high-dose groups. As
seen in Table 3, total liver damage in Group IV occurred
8 times more than in Group I. Similarly, apoptosis which
was detected in all experimental groups with increased
proportion depending on the dose was recorded as the
most important microscopic finding detected at the end
of the 18th hour. While 1-2 apoptotic nuclei were found
in each microscope area in the low dose groups (Groups
I and II), clusters of apoptotic particles were detected
in the regions in the high dose groups (Groups III and
IV) (Figure 1A). These cells were dark eosinophilic and
round cytoplasm, nuclei shrunk and separated from the
surrounding cells. Periportal lymphocytic infiltrations and
mild-to-moderate multifocal sinusoidal congestion were
found in the animals in the high dose groups (Groups III
and IV). In the experimental groups, megalocytosis was
not observed, but only sporadic karyomegalic hepatocytes
and numerous dual nucleated liver cells were found in the
high-dose groups (Figure 1B).
3.5.2. Microscopic changes in the liver of rats euthanized
at the end of the 6th week
Semiquantitative evaluation of histopathological findings
in liver at the end of the 6th week was summarized
in Table 4. At the end of this period, severe diffuse
megalocytosis characterized with the increased volume of
cell nuclei and cytoplasm was the most important finding
detected in Groups III and IV (Figure 1C). The diffuse
bile duct proliferation was observed in all experimental
groups, especially in Groups III and IV (Figure 1D). The
postnecrotic fibrosis and mild-moderate capsular fibrosis
were observed to accompany the abovementioned lesion
in Groups III and IV. Besides mononuclear cell infiltrations

Table 1. Mean liver weights at the end of the 18th hour according to the groups (g).
Tissue

Group I
X ± SX

Group II
X ± SX

Group III
X ± SX

Group IV
X ± SX

Group V
X ± SX

p

Liver

7.659 ± 0.757b

7.255 ± 1.234b

7.97 ± 0.788b

7.263 ± 1.330b

10.793 ± 0.739a

*

*: p < 0.05
Different superscripts (a,b) in the same row indicate significant difference (p < 0.05).
Table 2. Mean liver weights of groups at the end of the 6th week ( g).
Tissue

Group I
X ± SX

Group II
X ± SX

Group III
X ± SX

Group IV
X ± SX

Group V
X ± SX

p

Liver

10.016 ± 1.177bc

7.474 ± 1.884b

5.961 ± 1.087a

5.614 ± 0.276a

10.836 ± 0.884c

*

*: p < 0.05
Different superscripts (a,b,c) in the same row indicate significant difference (p < 0.05).
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Table 3. Semiquantitative evaluation of histopathological findings in livers at the end of
the 18th hour.
HD

FD

SC

N

ICI

TS

Group I

1

0

1

0

0

2

Group II

1

0

1

3

0

5

Group III

3

0

2

3

1

9

Group IV

4

1

4

5

2

16

Group V

0

0

0

0

0

0

HD: Hydropic degeneration, FD: Fatty degeneration, SC: Sinusoidal congestion, N:
Necrosis ICI: Inflammatory cell infiltration, TS: Total score.

Figure 1. A- Histopathological figure shows many apoptotic cells (arrows) in the liver of a rat in Group III at the end of the 18th hour,
H&E. B- Figure shows a large number of dual nucleated liver cells (arrows) of a rat in Group III at the end of the 18th hour, H&E. CMany megalocytosis (arrows) were seen in the liver of a rat in Group IV at the end of the 6th weeks, H&E. D- Bile duct proliferatios in
the liver in Group IV at the end of 6th weeks, H&E.

surrounding the necrotic areas were present in addition to
fatty change in hepatocytes. The intranuclear inclusions
were occasionally seen in hepatocytes in Group IV. The
severity of the liver damage in this period varied depending
on doses. Total liver damage in Group IV occurred 20
times more than in Group I.
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3.6. Immunohistochemical findings
TUNEL positive staining was present in all dosed groups of the
hepatocyte nuclei at the end of the 18th hour (Figures 2A and
2B). In parallel with the doses given in all euthanasia groups
at the end of the first 18th hour, the increase in the intensity of
positive staining compared to the 6th week was noted.
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Table 4. Semiquantitative evaluation of histopathological findings in livers at the end of the 6th week.
BDP

FD

PNF

CF

ICI

M

TS

Group I

0

0

0

0

0

1

1

Group II

1

1

1

1

1

3

8

Group III

3

1

3

2

2

4

15

Group IV

4

1

5

3

2

5

20

Group V

0

0

0

0

0

0

0

BDP: Bile duct proliferation, FD: Fatty degeneration, PNF: Postnecrotic fibrosis, CF: Capsular fibrosis,
ICI: Inflammatory cell infiltration, M: Megalocytosis, TS: Total score.

In Bax staining, in parallel with the doses given to the
experimental groups (50 mg/kg, 100 mg/kg, 150 mg/kg,
and 200 mg/kg), Bax immunostaining showed that the
cytoplasm of hepatocytes of the euthanatized animals were
strongly positively stained at the end of the 18th hours. At
the end of the 6th week, hepatocytes were slightly stained
(Figures 2C and 2D).
In Bcl-2 staining, in parallel with the doses given to the
experimental groups (50 mg/kg, 100 mg/kg, 150 mg/kg,
and 200 mg/kg) in the Bcl-2 immunostaining, cytoplasm
of liver hepatocytes were slightly positively stained at the
end of the 18th hour; at the end of the 6th week, very
severe positive staining was observed in the hepatocytes
of the animals that were exposed to 200 mg/kg; a decrease
in the severity of the staining was observed in the other
groups compared to the animals in the 200 mg/kg dose
group (Figures 2E and 2F).
In the PCNA immunostaining, mild staining of the
hepatocytes of the animals at the 18th hour was observed,
which was not different from each other in all groups. The
positive staining with increasing intensity was detected
depending on the given dose in the euthanasia animals at
the end of the 6th weeks.
4. Discussion
Monocrotaline is a macrocyclic PA derived from the
Crotalaria spectabilis plant [24]. In the present study,
single doses of 50 mg/kg, 100 mg/kg, 150 mg/kg, 200
mg/kg intraperitoneal monocrotaline injection were
determined to cause various macroscopic, microscopic,
immunohistochemical
findings.
Although
some
researchers [6] stated that monocrotaline doses of 200 mg/
kg and below did not cause hepatic injury and lesions were
only seen above 200 mg/kg doses. The low-dose-induced
liver lesions in the present study may be due to sensitivity
differences among the rat strains. Similarly, it has been
reported that significant variation in PA biotransformation
can exist between different rat strains [25]. Furthermore, in
another study, 30 mg/kg monocrotaline was administered
subcutaneously to rats and pulmonary hypertension was

reported to occur after 60 days. The researchers stated
that some animals in the study also caused damage to
the liver and kidneys. They suggested that the changes
in these organs could be caused by the disorders in
the cardiovascular system generated by pulmonary
hypertension [26]. Weight loss and low feed consumption
may be associated with deterioration of protein and
carbohydrate metabolism due to hepatotoxicity in the
liver [21,27-30]. Macroscopic findings of the current study
revealed excessive congestion, softening in the limbs,
trimming at the edges, coconut look, visceral lobes milier
and grayish color foci in the liver in parallel to the previous
reports [14,28,31-34].
Megalocytosis which is defined as the growth of the
cytoplasm and the nucleus has been reported as a specific
finding for PA toxication in many animal species and the
first finding in monocrotaline toxicity in mice [8,28,35,36].
In the present study, megalocytosis was also detected
in rats of all experimental groups euthanized at the end
of the 6th week. The degree of megalocytic lesions were
found to be mild, moderate, or severe depending on the
dose administered. Degenerative and necrotic hepatocytes
were observed in Groups III and IV which was evaluated
as long term period. Besides, bile duct proliferation in the
liver, sinusoidal congestion, parenchymal degeneration
and necrosis, mononuclear cell infiltrations were observed
in the present study as were reported in previous studies
[14,31,32]. Since monocrotalin causes significant
sinusoidal congestion, it is also used to induce experimental
sinusoidal congestion syndrome in rodents [37].
In conclusion, monocrotaline showed different
effects on the liver depending on dose and duration of
the exposure. Apoptotic changes were demonstrated by
TUNEL and Bax stainings, which were at the highest
level at the 18th hour after inoculation. The decrease in
apoptotic cells at the end of the 6th week was revealed
by PCNA and Bcl-2 staining. The increase in PCNA
staining at the end of the 6th week can be explained
by the continuation of the regeneration process in
unaffected hepatocytes. Besides the decreased apoptosis
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Figure 2. A- A few TUNEL positive cells were seen in the liver of a rat in Group I at the end of the 18th hour, TUNEL staining. B- Figure
shows many TUNEL positive cells in the liver of a rat in Group IV at the end of the 18th hour, TUNEL staining. C- Intensive Bax positive
staining was seen in the liver of a rat in Group IV at the end of the 18th hour, IHC staining. D- Moderate Bax positive staining was seen
in the liver of a rat in Group IV at the end of the 6th week, IHC staining. E- Moderate Bcl-2 positive staining was seen in the liver of a
rat in Group IV at the end of the 18th hour, IHC staining. F- Intensive Bcl-2 positive staining was seen in the liver of a rat in Group IV
at the end of the 6th week, IHC staining.

in long-term period toxication, the mitosis was
suppressed and led to the formation of megalocytosis
in certain cells (increased by the given dose). Single
dose of monocrotaline applied intraperitoneally to rats
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at doses of 50 mg/kg (Group I), 100 mg/kg (Group II),
150 mg/kg (Group III), and 200 mg/kg (Group IV)
caused megalocytosis and apoptosis in liver tissue. It was
concluded that the data of this study show that doses
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of 100 mg/kg and above of monocrotaline significantly
reduced the survival rate in 6-week trial studies.
Therefore, the use of doses below 100 mg/kg may be
recommended for long-term monocrotalin toxicity
studies.
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